Skip to content

Eda Zhuleku

Counsel

Munich

Zhuleku Eda
Eda Zhuleku

Counsel

Munich

Eda is a life sciences specialist lawyer with more than nine years’ experience in the sector.

Eda is an expert with respect to all regulatory issues that may be of interest to pharma, medical device; IVDs and life science businesses, including (early) benefit assessment, market access strategies, prescription of drugs and medical devices and eligibility for reimbursement. Further, she assists in every stage of the product life-cycle and advises pharma businesses, medical device and other life sciences businesses on challenges in terms of reimbursement and social law.

Related articles

drugs and vitamins

News: 03 December 2021

Allen & Overy`s Life Sciences team advises Vision Healthcare on the acquisition of Vitamaze

Allen & Overy has advised Vision Healthcare, a Belgium-based consumer healthcare company with a large portfolio of self-care brands and over-the-counter products in several European countries, on the…

Read more

Blog Post: 04 November 2021

European Commission unveils surprise amendment to In Vitro Diagnostics Regulation

Read more

Blog Post: 01 October 2021

EC consults on revision to pharmaceutical legislation

Read more

Blog Post: 13 August 2021

EU Clinical Trial Regulation to Take Effect on 31 January 2022

Read more

Expertise

Practices

Corporate and M&A

Sectors

Life Sciences

Office

Munich

Allen & Overy LLP
Maximilianstraße 35
80539 Munich

View office →

Qualifications

Professional

Certified Lawyer for Life Sciences since 2018

Pro-bono experience

  • Eda is a member of the Pro Bono Steering Committee in Germany

Published work

  • Zhuleku E. (2020) “Covid-19 and the Life Science Sector „Covid-19 and the Life Science Sector”, Practical Law ‐ London, Thomson Reuters
  • Zhuleku E, Professor Ehlers A, (2018) „Neues Bundesdatenschutzgesetz und EU‐Datenschutzverordnung Anpassungsbedarf bei den Unternehmen“ in pharmind Nr. 1, 82 , Edition Cantor Verlag
  • Zhuleku E, Professor Ehlers A, (2016) „Die FSA‐Kodizes und ihre Durchsetzung – wie konsequent ist das“ in: pharmind Nr. 6, 869, Edition Cantor Verlag
  • Zhuleku E, (2014) Die ärztliche Aufklärungspflicht nach dem Patientenrechtegesetz“ in: Der Diabetologe, Springer Medizin
  • Zhuleku E, (2013) „Rechtliche Stolpersteine des Bestandsmarktaufrufs“ in Highlights Magazin Ausgabe 8/13, Lehr & Visarius Verlag GmbH